Guardian Hanna Ellis-Peterson writes that India is at the center of global efforts to produce the covid vaccine.
As the largest global supplier of medicines and 60% of the world’s vaccine manufacturers, India has long been known as the “pharmacy of the world”.
Now, as the exciting hunting momentum of the Covid-19 vaccine accelerates, the country is increasingly playing a more strategic and central role in the development, production – and, crucially, of the possible future distribution of Covid shots.
.5. With over one million cases and nearly 100,000 deaths, India is also one of the countries most affected by the virus, surpassing the US. Then second.
A deal has already been struck for the Pune-based Serum Institute India F India to produce 1bn dose of ine xford / astrazeneka vaccine, which is seen as a pioneer in the vaccine race. In anticipation of its success, it has started production of nearly 2 million samples of the vaccine and is conducting Phase 3 human clinical trials on thousands of patients spread across 15 Covid-19 hotspots in India.
This week, the Serum Institute India f India said it is confident that the Astrazeneka vaccine will be ready by December and licensed for distribution in India by March.
Adar Poonawala, CEO of the Serum Institute of India, said he was “very optimistic” that more than one successful vaccine was imminent.
“I have recorded a lot of data in these vaccines which is very promising and three to four vaccines will be successful very soon,” Poonawala said.
The Serum Institute, which also launched human trials on the intranasal covid vaccine this week, is one of dozens of companies in India producing multi-greedy vaccines, with nearly 200 different varieties being developed worldwide. .
You can read the full story below:
.
